Latest News
Most investors just aren't seeing this e-commerce company's bigger picture.
Via The Motley Fool · May 12, 2025
Thinking about short-term savings? Find out if locking in a 6-month CD in May 2025 makes sense for you, plus smarter alternatives.
Via The Motley Fool · May 12, 2025
Via The Motley Fool · May 12, 2025
Monday.com topped Q1 earnings and revenue consensus. Sales guidance was in line.
Via Investor's Business Daily · May 12, 2025
Risk-on sentiment prevails as US-China trade talks show 'substantial progress,' according to both sides.
Via Talk Markets · May 12, 2025
The company has shown its revolutionary technology can deliver life-changing therapies. Now, it's about whether CRISPR Therapeutics can replicate the success across its promising pipeline.
Via The Motley Fool · May 12, 2025
Is MICROSOFT CORP (NASDAQ:MSFT) a Good Fit for Dividend Investing?
Via Chartmill · May 12, 2025
Via The Motley Fool · May 12, 2025
Bitcoin (CRYPTO: BTC) has seen a stratospheric rise since its inception in 2009. Those who identified its potential and invested when it was still in its infancy have witnessed returns that very few assets can compete with.
Via Benzinga · May 12, 2025
CATL, major Tesla's battery supplier, plans to raise $4B+ through a listing on Hong Kong's stock exchange, with a possible increase to $5.3B.
Via Benzinga · May 12, 2025
Read inspirational quotes about participating with the team, focusing on what matters most and picking the right side.
Via Investor's Business Daily · May 12, 2025
The AUD/USD pair is in an active upward phase with continued bullish momentum.
Via Talk Markets · May 12, 2025
Judge blocks land transfer for Rio Tinto and BHP mining project in Arizona due to Native American opposition and potential harm to sacred site.
Via Benzinga · May 12, 2025
Wholesale used-vehicle prices rose 4.9% in April from a year earlier.
Via Investor's Business Daily · May 12, 2025
Security technology and services company ADT (NYSE:ADT) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 6.5% year on year to $1.27 billion. The company expects the full year’s revenue to be around $5.13 billion, close to analysts’ estimates. Its non-GAAP profit of $0.32 per share was 63.7% above analysts’ consensus estimates.
Via StockStory · May 12, 2025
Commercial real estate firm CBRE (NYSE:CBRE) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 12.3% year on year to $8.91 billion. Its non-GAAP profit of $0.86 per share was 12.1% above analysts’ consensus estimates.
Via StockStory · May 12, 2025
A fundamental analysis of (NYSE:HIMS): HIMS & HERS HEALTH INC (NYSE:HIMS) showing high EPS and FCF growth while beating expectations
Via Chartmill · May 12, 2025
Boat and marine products retailer MarineMax (NYSE:HZO) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 8.3% year on year to $631.5 million. Its non-GAAP profit of $0.23 per share was 19% above analysts’ consensus estimates.
Via StockStory · May 12, 2025
Manufacturing company Dover (NYSE:DOV) fell short of the market’s revenue expectations in Q1 CY2025, with sales flat year on year at $1.87 billion. Its non-GAAP profit of $2.05 per share was 3.3% above analysts’ consensus estimates.
Via StockStory · May 12, 2025
Married couples' Social Security decisions can be very complicated, and these rules only make it harder.
Via The Motley Fool · May 12, 2025
Gains capped by OPEC+ plans to increase oil output in May/June, though April output dipped.
Via Talk Markets · May 12, 2025
Aerospace and defense company Textron (NYSE:TXT) announced better-than-expected revenue in Q1 CY2025, with sales up 5.5% year on year to $3.31 billion. Its non-GAAP profit of $1.28 per share was 12.5% above analysts’ consensus estimates.
Via StockStory · May 12, 2025
Higher education company Strategic Education (NASDAQ:STRA) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 4.6% year on year to $303.6 million. Its non-GAAP profit of $1.30 per share was 34.5% above analysts’ consensus estimates.
Via StockStory · May 12, 2025
Global pharmaceutical company Merck (NYSE:MRK) reported Q1 CY2025 results exceeding the market’s revenue expectations, but sales fell by 1.6% year on year to $15.53 billion. The company expects the full year’s revenue to be around $64.85 billion, close to analysts’ estimates. Its non-GAAP profit of $2.22 per share was 4% above analysts’ consensus estimates.
Via StockStory · May 12, 2025